Chickenpox Vaccine: Fetal Cells, Not Abortions

do chicken pox vaccines come from fetal abortions

The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and medical research. Vaccines that have been made using cell lines originally derived from fetal tissue include those against rabies, rubella, chickenpox, shingles, and adenovirus. Religious leaders from major religions, including Catholicism, have evaluated the use of these cells in making vaccines and determined that it is not sinful to accept vaccines made in this manner. However, the Catholic Church has encouraged its members to use alternative vaccines produced without human cell lines if possible. The Vatican has clarified that it is morally licit for Catholics to receive vaccines derived from fetal cell lines if there is a grave danger.

Characteristics Values
Chickenpox vaccine made from aborted fetal tissue? Yes
Religious views on using aborted fetal tissue in vaccines The Catholic Church is opposed to abortion and has encouraged its members to use alternative vaccines, but has indicated that it is acceptable to use vaccines derived from aborted fetal tissue if no alternative exists and there is a grave health risk.
Commercialization of aborted fetal tissue Not a new practice
Number of fetuses used in vaccine development Two
Year aborted fetal tissue was first obtained 1960s
Cell strains used WI-38, MRC-5
Vaccines made using aborted fetal tissue Rubella, Chickenpox, Hepatitis A, Rabies, Shingles, Adenovirus, Poliomyelitis, Smallpox

cyvaccine

Fetal tissue is used in vaccines and medical research

The use of fetal tissue in medical research and vaccine development is a highly contentious issue, with opposition from religious and pro-life groups. The Catholic Church, for example, has traditionally opposed the use of fetal tissue in vaccines and encouraged its members to use alternative vaccines produced without human cell lines. However, in 2005, the Pontifical Academy for Life concluded that parents may allow their children to receive vaccines derived from fetal tissue if no alternative exists and there is a significant health risk.

The Vatican's doctrinal office further clarified in 2020 that it is "morally licit" for Catholics to receive vaccines derived from fetal cell lines, especially during a grave health danger such as the COVID-19 pandemic. Nevertheless, the Catholic Church and other pro-life groups continue to advocate for the development of alternative vaccines that do not utilize aborted fetal tissue.

Despite the ethical debates surrounding the use of fetal tissue, many in the medical research community argue that it is essential for developing treatments and vaccines for various diseases. Fetal tissue is considered a "gold-standard" resource that enables laboratory-based research into human tissue and organ development. It has contributed significantly to our understanding of biology and the creation of new medical technologies.

Fetal tissue is also used to study and develop treatments for specific diseases, such as Parkinson's disease, Alzheimer's disease, diabetes, leukemia, spinal cord injuries, macular degeneration, and various forms of cancer. In some cases, fetal cells are transplanted into patients as a potential treatment.

The use of fetal tissue in vaccines and medical research remains a highly sensitive and controversial topic, with ongoing debates between religious and ethical concerns and the potential benefits to society in developing treatments and vaccines for life-threatening diseases.

cyvaccine

Religious views on fetal tissue in vaccines

The use of fetal tissue in vaccines is a controversial topic that has drawn varied responses from different religious groups. While some religions discourage vaccinations due to beliefs about divine protection or natural healing, others support vaccination as a means of fulfilling religious duties or preserving life.

Christianity, for example, encompasses a diverse range of denominations, each interpreting scripture and doctrine differently regarding health practices, including vaccination. Some Christians oppose the use of fetal tissue in vaccines due to their stance against abortion. Notably, the Catholic Church has addressed this issue, stating that it is morally permissible to accept vaccination when there are no alternatives and serious health risks are involved. The Church encourages individuals to make choices that avoid vaccines associated with aborted fetal tissue but permits their use if they have a remote association with evil and are necessary to preserve life.

Similarly, the Greek Orthodox Archdiocese of America has released statements on religious exemptions and COVID-19 vaccines, though the specific stance remains unclear. Protestant Christians, including evangelicals, have also expressed mixed views, with some planning to get vaccinated while others remain hesitant or opposed.

In contrast, other religious groups generally support vaccination and do not express specific concerns about fetal tissue. For instance, most Orthodox Jewish authorities endorse vaccinations as a religious duty to protect oneself and others. Islam also encourages seeking knowledge and protecting health, with most Islamic scholars supporting vaccination as a means to fulfill this duty. Hindu communities largely embrace modern medicine, including vaccinations, viewing them as a duty toward self-care and community well-being.

It is worth noting that within these religious groups, there may be variations in adherence levels due to personal beliefs, cultural practices, misinformation, or historical injustices that contribute to skepticism. Additionally, specific sects within Islam and Judaism may express hesitancy toward certain vaccines due to concerns about ingredients or ethical implications in their development.

cyvaccine

The pharmaceutical industry's use of fetal tissue

The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and in medical research. The practice involves growing viruses in cultured (lab-grown) cells originally derived from human fetal tissue. Fetal cells have been used in the development of vaccines for rabies, rubella, chickenpox, shingles, adenovirus, Ebola, tuberculosis, and COVID-19.

The use of fetal tissue in vaccine development has been a controversial topic, particularly from a religious and moral standpoint. The Catholic Church, for example, has historically opposed abortion and encouraged its members to use alternative vaccines produced without human cell lines if possible. However, in recent years, the Church has clarified that it is permissible for Catholics to receive vaccines derived from fetal cell lines if no alternative exists and there is a grave health risk.

The advantages of using fetal cells in vaccine development include their ability to grow indefinitely and their superior performance compared to animal cells in reducing the risk of transmitting animal diseases to humans. Fetal cells are also considered the "gold standard" in the pharmaceutical industry, enabling the global production of vaccines.

Despite the benefits, there are ongoing concerns about the commercialization of fetal tissue and its use in various industries, including cosmetics, food, and pharmaceuticals. The Uniform Anatomic Gift Act in the United States prohibits the buying or selling of fetal tissue, but allows companies to collect fees for handling and processing. The origin of fetal cells used in products is often not clearly advertised, making it challenging for consumers to make informed choices.

While the use of fetal tissue in vaccine development has raised ethical and religious debates, some religious leaders have evaluated the use of these cells in vaccines as not sinful. The development and use of alternative cell lines that do not originate from fetal tissue are also being encouraged to address these concerns.

cyvaccine

Ethical considerations of fetal tissue in vaccines

The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and medical research. This practice raises ethical considerations, particularly regarding the commercialisation of fetal tissue and the potential for encouraging elective abortions. Religious groups, such as the Catholic Church, have weighed in on the morality of using vaccines derived from fetal cell lines. While the Church opposes abortion, it has clarified that in the absence of alternatives and in cases of grave health risk, Catholics may acceptably receive such vaccines.

The use of fetal tissue in vaccine development involves growing viruses in cultured cells originally derived from human fetal tissue obtained from abortions. This practice has faced opposition on religious and moral grounds, with concerns about the commodification of fetal tissue and the potential for profit. The Catholic Church has encouraged its members to use alternative vaccines produced without human cell lines if possible, and to advocate for the development of morally acceptable alternatives.

However, it is important to note that the vaccines themselves do not contain any original fetal tissue, cells, or cell derivatives. The cell lines are purified from cell debris, although traces of human DNA fragments may remain. Fetal cells are favoured in vaccine development because viruses tend to grow better in human cells than animal cells, and fetal cells have not divided as many times as other cell types, allowing for longer use.

The ethical considerations surrounding the use of fetal tissue in vaccines are complex and multifaceted. While some oppose the practice on religious or moral grounds, others argue that the potential life-saving benefits of vaccines outweigh the ethical concerns. The development and use of alternative cell lines that do not originate from fetal tissue is an ongoing area of research and development.

In summary, the use of fetal tissue in vaccines raises ethical questions about the commercialisation of fetal tissue, the potential impact on abortion rates, and the role of religious beliefs in vaccine acceptance. Balancing these considerations with the potential health benefits of vaccines derived from fetal cell lines is an ongoing discussion in the scientific, medical, and religious communities.

cyvaccine

The development of alternative vaccines

The chickenpox vaccine was first developed in the 1970s by Michiaki Takahashi and colleagues in Japan. The Oka strain of the varicella virus was isolated from the fluid-filled blisters of a three-year-old child with chickenpox. This virus was then cultivated in guinea pig embryo cultures and tested on children between one and ten years old. The attenuated virus was then propagated in WI-38 cells, a human diploid cell line derived from the lung tissue of an aborted three-month-old female embryo.

Since its development, the chickenpox vaccine has been improved and is now commercially available. However, it is still derived from fetal tissue, and there has been opposition to the use of aborted fetal tissue in vaccine development on moral and religious grounds. The Catholic Church, for example, has encouraged its members to use alternative vaccines produced without human cell lines if possible.

Alternative vaccines that do not use aborted fetal tissue are available for some diseases, such as rabies. However, for other diseases, such as chickenpox, rubella, and hepatitis A, there are currently no alternative vaccines available that do not use aborted fetal cells.

Frequently asked questions

Chickenpox vaccines, such as VARIVAX, are made by growing viruses in fetal cells. The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and in medical research.

Fetal cells are cells that originated from abortions that took place decades ago. Fetal cells are used to make vaccines because viruses need cells to grow and tend to grow better in human cells than animal cells.

The Catholic Church is opposed to abortion. However, the Pontifical Academy for Life concluded in 2005 that parents may allow their children to receive vaccines made from aborted fetal tissue if no alternative exists and there is a grave health risk. In 2020, the Vatican's doctrinal office clarified that it is "morally licit" for Catholics to receive vaccines derived from fetal cell lines if there is a grave danger.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment